Facebook
X
LinkedIn
Forward
Aesthetic & Anti-Aging Medicine World Congress
The Aesthetic & Anti-Aging Medicine World Congress - Americas (AMWC Americas) conference addresses the science, practice and techniques of aesthetic surgery and medicine. With a faculty featuring the foremost researchers, educators and practitioners, this event will provide cutting-edge content to advance knowledge, enhance skills and techniques, and improve outcomes in the areas of aesthetic medicine, cosmetic surgery, and anti-aging. AMWC Americas will feature dynamic lectures, in-depth treatment and technique demonstrations, and real-world patient cases delivered by prominent experts at the forefront of the industry.
Target Audience
This activity has been designed to meet the educational needs of physicians, nurses and allied health professionals working directly within medical aesthetics, dermatology, plastic, and cosmetic surgery.
Learning Objectives
- Identify key principles of functional and anti-aging medicine, including hormone balance, nutrition, and lifestyle, and incorporate them into aesthetic treatment plans to enhance patient outcomes.
- Identify critical facial anatomical structures, tissue planes, and vasculature, recognize danger zones, and apply this knowledge to safe, precise injections and thread-lifting techniques.
- Apply ultrasound imaging to locate vessels and vital structures, enhance injection precision, reduce risks, and manage adverse events.
- Review biostimulatory and biorevitalizing therapies, including injection techniques, treatment protocols, and complication management to optimize skin and tissue regeneration.
- Identify common complications of aesthetic procedures, evaluate case studies, and implement preventive and reactive strategies to maintain safety.
- Understand injectable products for body contouring, injection techniques, combination with non-invasive therapies, and setting realistic patient expectations.
- Evaluate skin quality across all types, including skin of color, and integrate topical agents, energy-based devices, and injectables into safe, evidence-based combination protocols.
- Review regenerative modalities such as stem cells, PRP, exosomes, and polynucleotides, differentiate validated from emerging approaches, and integrate them safely into practice.
- Evaluate nonsurgical treatments for periorbital, lower face, and neck rejuvenation, including patient selection, combination protocols, and complication prevention.
- Analyze emerging laser, microneedling, and muscle stimulation technologies and their multi-dimensional, combination, and clinical applications for face and body.
- Examine evidence-based treatments and nonsurgical procedures for sexual health and genital aesthetics, integrating functional and aesthetic outcomes and managing complications.
- Evaluate hair restoration modalities, patient selection, combination strategies, and emerging technologies with practical implementation and outcome assessment.
- Review the role of key hormones in aging, bioidentical hormone therapy, and clinical considerations for safely integrating hormone optimization into aesthetic practice.
- Understand the link between nutrition, gut health, and immune function with skin quality and treatment response, and apply lifestyle strategies to enhance outcomes.
- Learn sequencing, timing, and combination strategies for treatments to optimize results, safety, and patient satisfaction across demographics and skin types.
- Apply peptide therapy and epigenetic insights to guide individualized, outcome-driven aesthetic protocols.
- Develop consultation, practice management, financial, marketing, and communication strategies to improve patient trust, retention, and practice success.
- Understand ideal male and female facial proportions, emerging trends, anatomical and lifestyle influences on aging, and tailor consultations and treatments accordingly.
- Understand basic facial anatomy, proportions, and aging changes.
- Learn fundamentals of neurotoxins, fillers, lasers, threads, and body shaping.
- Recognize key considerations for treating diverse skin types and skin of color.
- Apply essential safety principles to avoid and identify early complications.
Commercial Support
This activity is supported from an independent medical education grant from MERZ NORTH AMERICA, INC. (Merz) and in-kind support from BENEV Company Inc., Galderma, Miracu and Rejuran® USA.
DISCLOSURES | ||
Name | Relationship | Commercial Interest |
Noury Abdelkafe, MSc, DHM, PHD | N/A | Nothing to disclose |
Dr. Mariangel Acevedo | Speaker | SkyMedic – Aesthetic Medicine, SolerPharma – Aesthetic Medicine |
Shino Aguilera, DO | N/A | Nothing to disclose |
Eric Anderson, MD | N/A | Nothing to disclose |
Dr. Luis Assis | N/A | Nothing to disclose |
Dr. Daisy Ayim, | N/A | Nothing to disclose |
Dr. Jan Balczun | N/A | Nothing to disclose |
Sheila Barbarino, MD, FACS | Consultant | Hydrinity – Skincare, Mint PDO- Threads |
Dr. Keira Barr | Consultant | Sanofi |
Patrick Bitter, MD, FELLOW, AMERICAN ACADEMY OF DERMATOLOGY | Speaker | SCITON |
Dr. Lucie Chauvelin | N/A | Nothing to disclose |
Greg Chernoff, MD, FRCSC | N/A | Nothing to disclose |
Lanna Cheuck, DO | N/A | Nothing to disclose |
Dr. Suneel Chilukuri | Speaker | Advalight, Aerolase Lasers, Allergan Aesthetics, BTL, Clarity Rx, Crown Aesthetics, Evolus, Galderma, InMode, Merz, Prollenium Aesthetics, PCA Skin, Revance, Scientis, Sciton, Sente, Skin Medica |
Lesley Clark-Loeser, FAAD | Advisor
Researcher
Speaker | AnteAge, Neova, Revance, SkinBetter
Acclaro
Alastin/Galderma, Candela, BTL, Evolus, Prollenium, Scientis |
William Croley, MD | Advisor
Speaker | MedResults
Galderma, Aesthetic Management Solutions |
Natalie Curcio, MD, MPH, MMHC | Consultant
Independent contractor (including contracted research) | DefenAge
Revance Aesthetics |
Dr. Kristina Davidovic | N/A | Nothing to disclose |
Steven Dayan, MD | Consultant | AbbVie, Galderma |
Rafail De Oliveira, MD | N/A | Nothing to disclose |
Carolyn DeLucia, MD | Advisor
Consultant
Independent contractor (including contracted research)
Researcher | zeo scientifix
BTL
ALMA LASERS
APEX biomedical |
Derrick, DeSilva, MD | N/A | Nothing to disclose |
Madison Dini, JD | N/A | Nothing to disclose |
Dr. Kalpna Durairaj | Advisor | Allergan, AmSpa, Evolus, Galderma, Informa, Merz, Prollenium, Rapalogix |
Dr. Rachel Garcia | N/A | Nothing to disclose |
Shohreh Ghasemi, MD ,DDS ,MSC ,PHD (Head and neck oncology ) | N/A | Nothing to disclose |
Richard Goldfarb, MD, FACS | N/A | Nothing to disclose |
Enrico Guarino, MD | N/A | Nothing to disclose |
Dr. Deny Gutierrez | N/A | Nothing to disclose |
Dr. Azza Halim | N/A | Nothing to disclose |
Dr. Francisco Hernandez Gomez Crespo | N/A | Nothing to disclose |
|
|
|
Amanda Holden, MD | Individual stocks and stock options
Speaker | Repeat MD
BTL, Galderma |
Dr. Tarik Husain | Independent contractor (including contracted research) |
Apyx Medical, BodyESTIQ |
Dr.Sania Javaid | Speaker will verbally disclose relationships prior to session |
|
Cody Koch, MD, PhD | N/A | Nothing to disclose |
Dr. Irina Konopatkina | N/A | Nothing to disclose |
George Kroumpouzos, MD, PhD, FAAD | N/A | Nothing to disclose |
Dr. Gorana Kuka Epstein | Speaker will verbally disclose relationships prior to session |
|
Dr. Hanna Kurets | NA | Nothing to disclose |
Dr. Jesus Leal | N/A | Nothing to disclose |
Nathan LeBrasseur, PhD | Advisor | Cellanome, Eular Biologics, AbbVie, XPRIZE, Melaleuca Inc. |
Dr. Jenifer Levine | Consultant | Allergan, BTL, Galderma, Merz, revance, sciton |
Dr. Amy Lewis | Consultant | Rejencia, Sofwave |
Dr. Francisco Llano | N/A | Nothing to disclose |
Luciana Macedo de Oliveira | Speaker | Allergan Aesthetics |
JD McCoy, NMD | Advisor
Consultant
Researcher | Aura, Shapescale
Looped
BTL |
Dr. Grasiela Monteiro | Consultant
Researcher
Speaker | Allergan Aesthetics
Allergan Aesthetics
Allergan Aesthetics |
Serena Mraz, MD | N/A | Nothing to disclose |
Nima Naghshineh, MD, MSc, FACS | Advisor
Speaker | Allergan
Acclaro, MTF |
Jennifer Pearlman, MD CCFP ABAARM NCMP CFA | N/A | Nothing to disclose |
Carolina Pedrollo, MD | N/A | Nothing to disclose |
Dr. Kateryn Perez Willis | N/A | Nothing to disclose |
Olivia Pinto, MD | N/A | Nothing to disclose |
Dr. Jordan Plews | N/A | Nothing to disclose |
Dr. Dagne Pupo | Speaker will verbally disclose relationships prior to session |
|
Roshan Ravindran, MbChB | N/A | Nothing to disclose |
Dr. Rodolfo Reynoso | N/A | Nothing to disclose |
Jennifer Roelands, MD | Advisor | Physicians Choice |
Isabella Rosellini | N/A | Nothing to disclose |
Jeffrey Rosenthal, MD (Board Certified American Board of Plastic Surgery) |
N/A |
Nothing to disclose |
Terri Ross | N/A | Nothing to disclose |
Dr. Adam Rubinstein | Advisor
Speaker | Elixir MD, Qthero
Apyx, Sofwave, Tiger |
Roxane Scemla, MD | N/A | Nothing to disclose |
Adam Scheiner, MD | N/A | Nothing to disclose |
Dr. Todd Schlesinger | Advisor
Consultant
Researcher
Speaker | Avant Health, Chronicle Medical Software, Derma-Gene, SkinCure Oncology
Almirall, Galderma, Regeneron, Abbvie, SUN, Feldan Therapeutics, RBC, Lilly, Janssen,Novartis, Pfizer, SkinCure Oncology, Verrica
Almirall, Galderma, Regeneron, Abbvie, Medicus, SUN
Almirall, Arcutis, Benev, Galderma, Regeneron, BMS, UCB. SUN, Lilly, Janssen |
Gabriela Schwartzmann, MD | Speaker | Allergan |
Sachin Shridharani, MD, FACS | Consultant | Allergan, Revance, Tiger Aesthetics |
Dr. Ornella Siciliano | N/A | Nothing to disclose |
Dr. Melinda Silva | Speaker | BTL Aeshthetics |
Dr. Robyn Siperstein | Advisor
Consultant
Researcher
Speaker | Revance
Allergan
Abbvie, Galderma
Allergan, Galderma, Revance |
Blakelee Paige Smith, MSN, APRN, AGPCNP-BC, NP-C | Consultant | Galderma, Hydrafacial |
Professor Lee Smith | N/A | Nothing to disclose |
Steven Sorr, NMD | Advisor
Ownership interest
Speaker | Benev
Source of Health
Canfield, Galderma, Toskani, WiQo |
Nenad Stankovic, DDS | N/A | Nothing to disclose |
Dr. Aris Sterodimas | Speaker will verbally disclose relationships prior to session |
|
Mark Tager, MD | Advisor
Consultant
Seaker | Calocurb, Vagus Nerve Society
Rejencia
Designs for Health, Fagron Genomic, MicroBiome Labs |
Dr. Jesper Thulesen, phd, drmed, febo | Speaker will verbally disclose relationships prior to session |
|
Dr. Gisela Trajano-Sarmiento | Speaker will verbally disclose relationships prior to session |
|
Professor Patrick Treacy, MB.BS H. Dip Dermatology | N/A | Nothing to disclose |
Christin Trujillo | N/A | Nothing to disclose |
Omotola Tsarumi, MD | N/A | Nothing to disclose |
Lyris Verdura-Dominic, BSN, MSN, APRN, FNP-BC | Consultant
Independent contractor (including contracted research)
Speaker | HansBio Med / MINT
Benev, Toskani, B.A.I. Biosciences, Inc., Empire Medical Training, Informa PLC, Connecticut Dermatology NP & PA Organization, Aesthetic Next LLC
Miracu, PharmaResearch Products Co., Ltd, CAREStream America, Illari, Med-Aesthetics America, LLC, Medical Aesthetic Art Institute, LLC |
Ana Victoria, MD | Consultant
Researcher | Galderma
Sling, Candela Medical |
Bianca Viscomi, MD | N/A | Nothing to disclose |
Steven Weiner, MD | Speaker | Galderma, Tixel, BENEV, Clarius, Rion |
|
|
|
Dr. Cecile Winter | Advisor
Speaker | Galderma
Allergan, Croma, Vivacy |
Ekta Yadav, MD, MBA, MSc | N/A | Nothing to disclose |
Kyuho Yi | N/A | Nothing to disclose |
Dorothy Caputo, MA, BSN, RN - President, AKH Inc., Advancing Knowledge in Healthcare | N/A | Nothing to disclose |
Rebecca Lakofsky, RN Planner/Reviewer | N/A | Nothing to disclose |
AKH Inc Staff and Planners | N/A | Nothing to disclose |
Informa Connect Staff and Planners | N/A | Nothing to disclose |
All of the relevant financial relationships listed for these individuals have been mitigated. | ||
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Informa Connect. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 19.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 19.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Credit being awarded: 19.5 ANCC contact hours.
Available Credit
- 19.50 AMA PRA Category 1 Credit™
- 19.50 ANCC
- 19.50 Attendance